SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,536,000 | -6.0% | 398,885 | +5.0% | 1.48% | +8.5% |
| Q1 2022 | $12,278,000 | +10.8% | 379,875 | -0.0% | 1.36% | +11.4% |
| Q4 2021 | $11,080,000 | +25.5% | 379,975 | +14.7% | 1.22% | +19.3% |
| Q3 2021 | $8,832,000 | +54.0% | 331,140 | +102.3% | 1.02% | +15.6% |
| Q1 2019 | $5,736,000 | +47.7% | 163,691 | +40.0% | 0.88% | +69.5% |
| Q4 2018 | $3,883,000 | -68.4% | 116,886 | -52.2% | 0.52% | -53.2% |
| Q3 2018 | $12,302,000 | -19.8% | 244,356 | -4.7% | 1.12% | -21.0% |
| Q2 2018 | $15,346,000 | +18.8% | 256,401 | -9.1% | 1.41% | +11.4% |
| Q1 2018 | $12,918,000 | -14.1% | 282,056 | -25.3% | 1.27% | +19.3% |
| Q4 2017 | $15,041,000 | +5.9% | 377,461 | +6.3% | 1.06% | +13.7% |
| Q3 2017 | $14,200,000 | +54.9% | 354,955 | +66.8% | 0.94% | +52.0% |
| Q2 2017 | $9,169,000 | – | 212,740 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |